Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 68
- Press releases
Panaxia And Neuraxpharm: First Export Of Medical Cannabis Sublingual Tablets To France
The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry Both companies have previously issued their premium oils to patients in France PANAXIA Labs Israel Ltd (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical cannabis products in pharmaceutical quality, and Neuraxpharm…
- Press releases
DEMECAN Receives GMP Certificate For Cannabis Production Facility
*Saxony Awards Manufacturing Licence For Medical Cannabis*DEMECAN ensures compliance with highest quality criteria*Way cleared for first cannabis flower delivery “Made in Saxony” DEMECAN, the only independent German producer of medicinal cannabis, has been granted a manufacturing license in accordance with §13 AMG (German Medicines Act) and GMP (Good Manufacturing Practice) certification for its production facility…
- Medical
First export of sublingual tablets to French medical cannabis programme
The tablets have been exported by Israel-based Panaxia Labs and European company Neuraxpharm.
- Cultivation
The year mainstream companies enter cannabis?
GOING MAINSTREAM Will more mainstream companies invest in cannabis in 2022?
- Pharmaceutical
European Cannabis Round-Up; GW Pharma’s Cannabis Pipeline, Irish CBD In Court, UK Medical Cannabis Price Row, Italian Referendum, Poland And Malta
GW Pharmaceuticals has released further details of its cannabis development pipeline.
- Medical
South African company planning to export cannabinoids to UK and EU
The company is the first in the country to receive a licence for the manufacture, import and export cannabinoids.
- Cultivation
Cannabis deals in the cannabis news
$$$ Deals, deals, deals US MSOs are already making (and terminating) big moves in 2022: Massachusetts-based Curaleaf closed its $211 million acquisition of Arizona dispensary chain Bloom, which operates 13 shops in the state.
- Pharmaceutical
Thailand to propose removing cannabis from controlled substances list
Thailand was the first nation in Southeast Asia to approve medical cannabis in 2018
- Medical
AMP exclusive enters cannabis extract distribution agreement in Germany
The three-year agreement will see AMP become the exclusive distribution partner for Australia-based Little Green Pharma.
- Medical
Boost For Danish Medical Cannabis Patients Following Canntrust Scandal
FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is likely to provide a boost to the faltering scheme.
- Pharmaceutical
Oxford Cannabinoid Technologies sees positive progression
Oxford Cannabinoid Technologies Holdings has begun 2022 with a positive start and has announced a new date for the start of its Phase I trial.
- Medical
AMP Alternative Medical Products begins Dronabinol sales in Germany
The company is a medical cannabis subsidiary of Greenrise Global Brands.
